China approves two experimental Covid-19 vaccines for clinical trials中国批准了两种用于临床试验的实验性Covid-19疫苗China has approved early-stage human tests for two experimental vaccines to combat the new coronavirus that killed over 100,000 people worldwide, state media Xinhua reported on Tuesday.

据新华社周二报道，中国已批准两种实验性疫苗的早期人体试验，以对抗新型冠状病毒。

该病毒在全世界造成10万人死亡。

The vaccines are being developed by a Beijing-based unit of Nasdaq-listed Sinovac Biotech, and by the Wuhan Institute of Biological Products, an affiliate of state-owned China National Pharmaceutical Group.

这些疫苗是由纳斯达克上市公司科兴生物科技(Sinovac Biotech)的北京子公司和国有企业中国医药集团(China National Pharmaceutical Group)的子公司武汉生物制品研究所(Wuhan Institute of Biological Products)联合开发的。

In March, China have the green-light for another clinical trial for a coronavirus vaccine candidate developed by military-backed China's Academy of Military Medical Sciences and HK-listed biotech firm CanSino Bio, shortly after US drug developer Moderna said it had begun human tests for their vaccine with the U.

S.

National Institutes of Health.

今年3月，在美国药物开发商 Moderna 宣布已经开始在美国国立卫生研究院进行人体试验之后不久，中国为由军方支持的中国军事医学科学院，和在香港上市的生物技术公司 CanSino Bio 开发的冠状病毒候选疫苗的另一项临床试验开了绿灯。

Vaccine needed to stop virus spread世界需要疫苗来阻止病毒传播The World Health Organization (WHO) said Monday that a safe and effective vaccine would be needed to fully halt the spread of Covid-19, which has killed more than 114,000 people worldwide.

世界卫生组织(WHO)周一表示，需要一种安全有效的疫苗，来完全阻止已导致全球11.

4万人死亡的Covid-19的传播。

"Our global connectedness means the risk of re-introduction and resurgence of Covid-19 will continue," WHO Director-General Tedros Adhanom Ghebreyesus told a virtual briefing from Geneva, stressing that "ultimately, the development and delivery of a safe and effective vaccine will be needed to fully interrupt transmission.

"世卫组织总干事Tedros Adhanom Ghebreyesus在日内瓦举行的一次虚拟新闻发布会上说:我们的全球连通，意味着再次感染和复苏covid19的风险将继续存在。

”他强调，最终将需要开发和提供一种安全有效的疫苗，来完全阻断新型冠状病毒的传播。

”【中国批准了两种用于临床试验的实验性Covid-19疫苗查看网站：[db:时间]】